The postherpetic neuralgia treatment market is largely dominated by large vendors who are competing based on market penetration and distribution. However, the consolidated nature of the post herpetic neuralgia treatment market fails to increase the profitability of the business owing to loss of patents and poor efficacy and efficiency of the treatment.
Industry: Healthcare
Published Date: October-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 214
Report ID: PMRREP14506
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Post Herpetic Neuralgia Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.2. Key Trends
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Global Pharmaceutical Outlook
6. Key Inclusions
6.1. Disease Epidemiology
6.2. PEST Analysis
6.3. Regulatory Landscape
7. North America Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
7.4.1. Drugs
7.4.1.1. Anticonvulsants
7.4.1.2. Antidepressants
7.4.1.3. Opioids
7.4.2. Patches
7.4.2.1. Lidocaine Patches
7.4.2.2. Capsaicin Patches
7.4.3. Steroid Injectable
7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
7.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.6.1. Institutional Sales
7.6.1.1. Hospital Pharmacies
7.6.1.2. Clinics
7.6.2. Retail Sales
7.6.2.1. Retail Pharmacies
7.6.2.2. Drug Stores
7.6.2.3. Mail Order Pharmacies
7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Treatment Type
7.8.3. By Distribution Channel
7.9. Key Representative Market Participants
8. Latin America Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
8.2.1. Argentina
8.2.2. Brazil
8.2.3. Mexico
8.2.4. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
8.4.1. Drugs
8.4.1.1. Anticonvulsants
8.4.1.2. Antidepressants
8.4.1.3. Opioids
8.4.2. Patches
8.4.2.1. Lidocaine Patches
8.4.2.2. Capsaicin Patches
8.4.3. Steroid Injectable
8.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
8.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.6.1. Institutional Sales
8.6.1.1. Hospital Pharmacies
8.6.1.2. Clinics
8.6.2. Retail Sales
8.6.2.1. Retail Pharmacies
8.6.2.2. Drug Stores
8.6.2.3. Mail Order Pharmacies
8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Treatment Type
8.8.3. By Distribution Channel
8.9. Key Representative Market Participants
9. Europe Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. Spain
9.2.5. U.K.
9.2.6. Poland
9.2.7. Russia
9.2.8. Rest of Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
9.4.1. Drugs
9.4.1.1. Anticonvulsants
9.4.1.2. Antidepressants
9.4.1.3. Opioids
9.4.2. Patches
9.4.2.1. Lidocaine Patches
9.4.2.2. Capsaicin Patches
9.4.3. Steroid Injectable
9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
9.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.6.1. Institutional Sales
9.6.1.1. Hospital Pharmacies
9.6.1.2. Clinics
9.6.2. Retail Sales
9.6.2.1. Retail Pharmacies
9.6.2.2. Drug Stores
9.6.2.3. Mail Order Pharmacies
9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Treatment Type
9.8.3. By Distribution Channel
9.9. Key Representative Market Participants
10. Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
10.2.1. India
10.2.2. Australia and New Zealand
10.2.3. Japan
10.2.4. Rest of Asia Pacific Excluding China
10.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
10.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
10.4.1. Drugs
10.4.1.1. Anticonvulsants
10.4.1.2. Antidepressants
10.4.1.3. Opioids
10.4.2. Patches
10.4.2.1. Lidocaine Patches
10.4.2.2. Capsaicin Patches
10.4.3. Steroid Injectable
10.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.6.1. Institutional Sales
10.6.1.1. Hospital Pharmacies
10.6.1.2. Clinics
10.6.2. Retail Sales
10.6.2.1. Retail Pharmacies
10.6.2.2. Drug Stores
10.6.2.3. Mail Order Pharmacies
10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
10.8. Market Attractiveness Analysis
10.8.1. By Country
10.8.2. By Treatment Type
10.8.3. By Distribution Channel
10.9. Key Representative Market Participants and Intensity Map
11. Middle East & Africa Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
11.2.1. South Africa
11.2.2. GCC Countries
11.2.3. Rest of MEA
11.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
11.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
11.4.1. Drugs
11.4.1.1. Anticonvulsants
11.4.1.2. Antidepressants
11.4.1.3. Opioids
11.4.2. Patches
11.4.2.1. Lidocaine Patches
11.4.2.2. Capsaicin Patches
11.4.3. Steroid Injectable
11.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.6.1. Institutional Sales
11.6.1.1. Hospital Pharmacies
11.6.1.2. Clinics
11.6.2. Retail Sales
11.6.2.1. Retail Pharmacies
11.6.2.2. Drug Stores
11.6.2.3. Mail Order Pharmacies
11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
11.8. Market Attractiveness Analysis
11.8.1. By Country
11.8.2. By Treatment Type
11.8.3. By Distribution Channel
11.9. Key Representative Market Participants
12. China Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
12.2.1. Drugs
12.2.1.1. Anticonvulsants
12.2.1.2. Antidepressants
12.2.1.3. Opioids
12.2.2. Patches
12.2.2.1. Lidocaine Patches
12.2.2.2. Capsaicin Patches
12.2.3. Steroid Injectable
12.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
12.4. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.4.1. Institutional Sales
12.4.1.1. Hospital Pharmacies
12.4.1.2. Clinics
12.4.2. Retail Sales
12.4.2.1. Retail Pharmacies
12.4.2.2. Drug Stores
12.4.2.3. Mail Order Pharmacies
12.5. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Treatment Type
12.6.3. By Distribution Channel
12.7. Key Representative Market Participants
13. Forecast Factors: Relevance and Impact
14. Forecast Assumptions
15. Market Structure Analysis
15.1. Market Structure by Tier of Companies
15.2. Market Share Analysis % (2017)
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Company Deep Dive
16.3.1. Pfizer Inc.
16.3.1.1. Overview
16.3.1.2. Product and Application Portfolio
16.3.1.3. Production Footprint
16.3.1.4. Sales Footprint
16.3.1.5. Channel Footprint
16.3.1.6. Strategy
16.3.1.6.1. Marketing Strategy
16.3.1.6.2. Product Strategy
16.3.1.6.3. Channel Strategy
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.2.1. Overview
16.3.2.2. Product and Application Portfolio
16.3.2.3. Production Footprint
16.3.2.4. Sales Footprint
16.3.2.5. Channel Footprint
16.3.2.6. Strategy
16.3.2.6.1. Marketing Strategy
16.3.2.6.2. Product Strategy
16.3.2.6.3. Channel Strategy
16.3.3. Mylan N.V.
16.3.3.1. Overview
16.3.3.2. Product and Application Portfolio
16.3.3.3. Production Footprint
16.3.3.4. Sales Footprint
16.3.3.5. Channel Footprint
16.3.3.6. Strategy
16.3.3.6.1. Marketing Strategy
16.3.3.6.2. Product Strategy
16.3.3.6.3. Channel Strategy
16.3.4. Endo Pharmaceuticals Inc.
16.3.4.1. Overview
16.3.4.2. Product and Application Portfolio
16.3.4.3. Production Footprint
16.3.4.4. Sales Footprint
16.3.4.5. Channel Footprint
16.3.4.6. Strategy
16.3.4.6.1. Marketing Strategy
16.3.4.6.2. Product Strategy
16.3.4.6.3. Channel Strategy
16.3.5. Daiichi Sankyo
16.3.5.1. Overview
16.3.5.2. Product and Application Portfolio
16.3.5.3. Production Footprint
16.3.5.4. Sales Footprint
16.3.5.5. Channel Footprint
16.3.5.6. Strategy
16.3.5.6.1. Marketing Strategy
16.3.5.6.2. Product Strategy
16.3.5.6.3. Channel Strategy
16.3.6. Acorda Therapeutics
16.3.6.1. Overview
16.3.6.2. Product and Application Portfolio
16.3.6.3. Production Footprint
16.3.6.4. Sales Footprint
16.3.6.5. Channel Footprint
16.3.6.6. Strategy
16.3.6.6.1. Marketing Strategy
16.3.6.6.2. Product Strategy
16.3.6.6.3. Channel Strategy
16.3.7. Purdue Pharma L.P
16.3.7.1. Overview
16.3.7.2. Product and Application Portfolio
16.3.7.3. Production Footprint
16.3.7.4. Sales Footprint
16.3.7.5. Channel Footprint
16.3.7.6. Strategy
16.3.7.6.1. Marketing Strategy
16.3.7.6.2. Product Strategy
16.3.7.6.3. Channel Strategy
16.3.8. Teikoku Pharma USA, Inc.
16.3.8.1. Overview
16.3.8.2. Product and Application Portfolio
16.3.8.3. Production Footprint
16.3.8.4. Sales Footprint
16.3.8.5. Channel Footprint
16.3.8.6. Strategy
16.3.8.6.1. Marketing Strategy
16.3.8.6.2. Product Strategy
16.3.8.6.3. Channel Strategy
16.3.9. Janssen Pharmaceuticals, Inc.
16.3.9.1. Overview
16.3.9.2. Product and Application Portfolio
16.3.9.3. Production Footprint
16.3.9.4. Sales Footprint
16.3.9.5. Channel Footprint
16.3.9.6. Strategy
16.3.9.6.1. Marketing Strategy
16.3.9.6.2. Product Strategy
16.3.9.6.3. Channel Strategy
17. Global Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Region
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
17.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
17.3.1. North America
17.3.2. Latin America
17.3.3. Europe
17.3.4. Asia Pacific Excluding China
17.3.5. Middle East & Africa
17.3.6. China
17.4. Market Attractiveness Analysis By Region
18. Global Post Herpetic Neuralgia Treatment Analysis 2013–2017 and Forecast 2018–2026, By Treatment Type
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
18.2.1. Drugs
18.2.1.1. Opioids
18.2.1.2. Anticonvulsants
18.2.1.3. Antidepressants
18.2.2. Patches
18.2.2.1. Lidocaine Patches
18.2.2.2. Capsaicin Patches
18.2.3. Steroid Injectable
18.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
18.4. Market Attractiveness Analysis By Treatment Type
19. Global Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
19.2.1. Institutional Sales
19.2.1.1. Hospital Pharmacies
19.2.1.2. Clinics
19.2.2. Retail Sales
19.2.2.1. Retail Pharmacies
19.2.2.2. Drug Stores
19.2.2.3. Mail Order Pharmacies
19.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
19.4. Market Attractiveness Analysis By Distribution Channel
20. Global Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
20.1. Market Value Share Analysis By All Segment
20.2. Y-o-Y Growth Analysis By All Segment
20.3. Absolute $ Opportunity
21. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Prevalence of Post Herpetic Neuralgia in North America, 2017
Table 04: Prevalence of Post Herpetic Neuralgia in Latin America, 2017
Table 05: Prevalence of Post Herpetic Neuralgia in Asia Pacific excluding China , 2017
Table 06: Prevalence of Post Herpetic Neuralgia in Europe, 2017
Table 07: North America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08: North America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 09: North America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 10: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 11: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 12: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 13: Europe Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: Europe Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 15: Europe Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 16: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 17: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 18: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 19: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 20: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 21: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 22: China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23: China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 24: China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 25: Competition Dashboard
Table 26: Competition Dashboard
Table 27: Post Herpetic Neuralgia Treatment Market Value (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region
Table 28: Global Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 29: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Post Herpetic Neuralgia Treatment Market Value Share By Treatment Type (2018 E)
Figure 02: Global Post Herpetic Neuralgia Treatment Market Value Share By Distribution Channels (2018 E)
Figure 03: Global Post Herpetic Neuralgia Treatment Market Value Share By Regions (2018 E)
Figure 04: GDP (US$ Trillion) and Healthcare Expenditure % (2017)
Figure 05: Net National income, Income Growth and Employment (2014)
Figure 06: Zoster and Post Herpetic Neuralgia Rate (2017)
Figure 07: Opioids Related Deaths, 2017
Figure 08: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 09: North America Post Herpetic Neuralgia Treatment Market Value Share (%) By Country (2017)
Figure 10: North America Post Herpetic Neuralgia Treatment Market Value Share (%) By Treatment Type (2017)
Figure 11: North America Post Herpetic Neuralgia Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 12: North America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017
Figure 13: North America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 14: U.S. Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 15: U.S. Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 16: Canada Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 17: Canada Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 18: North America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Drugs
Figure 19: North America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Drugs
Figure 20: North America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Patches
Figure 21: North America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Patches
Figure 22: North America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 23: North America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 24: North America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Institutional Sales
Figure 25: North America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Institutional Sales
Figure 26: North America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Retail Sales
Figure 27: North America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Retail Sales
Figure 28: North America Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Country
Figure 29: North America Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 30: North America Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 31: Latin America Post Herpetic Neuralgia Treatment Market Value Share (%) By Country (2017)
Figure 32: Latin America Post Herpetic Neuralgia Treatment Market Value Share (%) By Treatment Type (2017)
Figure 33: Latin America Post Herpetic Neuralgia Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 34: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017
Figure 35: Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 36: Argentina Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 37: Argentina Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 38: Brazil Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 39: Brazil Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 40: Mexico Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Mexico Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 42: Rest of Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: Rest of Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 44: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Drugs
Figure 45: Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Drugs
Figure 46: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Patches
Figure 47: Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Patches
Figure 48: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 49: Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 50: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Institutional Sales
Figure 51: Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Institutional Sales
Figure 52: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Retail Sales
Figure 53: Latin America Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Retail Sales
Figure 54: Latin America Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Country
Figure 55: Latin America Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 56: Latin America Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 57: Europe Post Herpetic Neuralgia Treatment Market Value Share (%) By Country (2017)
Figure 58: Europe Post Herpetic Neuralgia Treatment Market Value Share (%) By Treatment Type (2017)
Figure 59: Europe Post Herpetic Neuralgia Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 60: Europe Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017
Figure 61: Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 62: Germany Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 63: Germany Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 64: France Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 65: France Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 66: Italy Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 67: Italy Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 68: Spain Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 69: Spain Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 70: U.K. Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 71: U.K. Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 72: Poland Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 73: Poland Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 74: Russia Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 75: Russia Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 76: Rest of Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 77: Rest of Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 78: Europe Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Drugs
Figure 79: Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Drugs
Figure 80: Europe Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Patches
Figure 81: Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Patches
Figure 82: Europe Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 83: Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 84: Europe Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Institutional Sales
Figure 85: Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Institutional Sales
Figure 86: Europe Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Retail Sales
Figure 87: Europe Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Retail Sales
Figure 88: Europe Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Country
Figure 89: Europe Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 90: Europe Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 91: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Value Share (%) By Country (2017)
Figure 92: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Value Share (%) By Treatment Type (2017)
Figure 93: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 94: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017
Figure 95: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 96: Japan Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 97: Japan Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 98: India Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 99: India Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 100: Australia and New Zealand Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 101: Australia and New Zealand Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 102: Rest of Asia Pacific Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 103: Rest of Asia Pacific Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 104: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Drugs
Figure 105: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Drugs
Figure 106: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Patches
Figure 107: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Patches
Figure 108: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 109: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 110: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Institutional Sales
Figure 111: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Institutional Sales
Figure 112: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Retail Sales
Figure 113: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Retail Sales
Figure 114: Asia Pacific Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Country
Figure 115: Asia Pacific Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 116: Asia Pacific Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 117: Middle East & Africa Post Herpetic Neuralgia Treatment Market Value Share (%) By Country (2017)
Figure 118: Middle East & Africa Post Herpetic Neuralgia Treatment Market Value Share (%) By Treatment Type (2017)
Figure 119: Middle East & Africa Post Herpetic Neuralgia Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 120: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017
Figure 121: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 122: GCC Countries Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 123: GCC Countries Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 124: South Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 125: South Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 126: Rest of Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 127: Rest of Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 128: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Drugs
Figure 129: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Drugs
Figure 130: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Patches
Figure 131: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Patches
Figure 132: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 133: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 134: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Institutional Sales
Figure 135: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Institutional Sales
Figure 136: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Retail Sales
Figure 137: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Retail Sales
Figure 138: Middle East & Africa Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Country
Figure 139: Middle East & Africa Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 140: Middle East & Africa Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 141: China Post Herpetic Neuralgia Treatment Market Value Share (%) By Treatment Type (2017)
Figure 142: China Post Herpetic Neuralgia Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 143: China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017
Figure 144: China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 145: China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Drugs
Figure 146: China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Drugs
Figure 147: China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Patches
Figure 148: China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Patches
Figure 149: China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Steroid Injectable
Figure 150: China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Steroid Injectable
Figure 151: China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Institutional Sales
Figure 152: China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Institutional Sales
Figure 153: China Post Herpetic Neuralgia Treatment Market Size Analysis, 2013–2017, By Retail Sales
Figure 154: China Post Herpetic Neuralgia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Retail Sales
Figure 155: China Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 156: China Post Herpetic Neuralgia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 157: Global Post Herpetic Neuralgia Treatment Market 2017, Parent Market
Figure 158: Global Post Herpetic Neuralgia Treatment Market Value 2017
Figure 159: Global Post Herpetic Neuralgia treatment Market Share Analysis (%) By Region, 2018 & 2026
Figure 160: Global Post Herpetic Neuralgia treatment Market Y-o-Y Growth (%) By Region, 2017–2026
Figure 161: Global Post Herpetic Neuralgia Treatment Market Attractiveness Analysis By Region, 2018–2026
Figure 162: Global Post Herpetic Neuralgia treatment Market Share
Figure 163: Post Herpetic Neuralgia treatment Market Y-o-Y Growth (%) By Treatment Type, 2017–2026
Figure 164: Global Post Herpetic Neuralgia treatment Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 165: Global Post Herpetic Neuralgia Treatment Market Share Analysis (%) By Distribution Channels, 2018 & 2026
Figure 166: Post Herpetic Neuralgia Treatment Market Y-o-Y Growth (%) By Distribution Channels, 2017–2026
Figure 167: Global Post Herpetic Neuralgia Treatment Market Attractiveness Analysis By Distribution Channels, 2018–2026
Figure 168: Global Post Herpetic Neuralgia Treatment Market Value Analysis and Forecast, 2017–2026 (US$ Mn)
Figure 169: Global Post Herpetic Neuralgia Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2026
